Search Oncotarget
2,956 results found
— showing 21–40
SETDB1 amplification in osteosarcomas: Insights from its role in healthy tissues and other cancer types Review
Keywords: SETDB1, cancer epigenetics, tumor immunogenicity, mesenchymal differentiation in osteosarcoma
Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report Case Report
Keywords: ROS1 rearrangement, RET rearrangement, non-small cell lung cancer, targeted therapy, case report
Assessment of cfDNA release dynamics during colorectal cancer surgery Research Paper
Keywords: colorectal cancer, cfDNA, surgery
Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms Review
Keywords: breast cancer, HER2-low, genomics
Gene regulatory network and signalling pathway rewiring: How blood cancer cells shift their shapes to evade drug treatment Editorial
Keywords: acute myeloid leukaemia, gene regulatory networks, aberrant growth factor signaling, transcription, RUNX1/AP-1 axis
Initiation of tumor dormancy by the lymphovascular embolus Research Paper
Keywords: dormancy, lymphovascular embolus, mTOR, E-cadherin proteolysis
Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition Research Paper
Keywords: 3E10, cell penetration, nucleic acid binding, nucleic acid delivery, RAD51
Addendum: Transfected SARS-CoV-2 spike DNA for mammalian cell expression inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells and increases cancer cell viability after chemotherapy exposure Addendum
Using early on-treatment circulating tumor DNA measurements as response assessment in metastatic castration resistant prostate cancer Editorial
Keywords: ctDNA, prostate cancer, liquid biopsy, biomarker, androgen receptor pathway inhibitors
Targeting ABC transporters in PDAC – past, present, or future? Editorial
Keywords: PDAC, chemoresistance, ABCB1
Starving cancer cells to enhance DNA damage and immunotherapy response Research Perspective
Keywords: amino acid depletion, DNA damage, DNA repair, Immunotherapy, tumor immunity
Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel therapy Research Paper
Keywords: decitabine, HDAC inhibitors, pancreatic cancer, PARP inhibitors, synergistic cytotoxicity
The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune response Research Paper
Keywords: CLK kinases inhibitors, EMT, antiviral immune response, microtubules, metastasis
Cyclin D1 expression in penile cancer Research Paper
Keywords: immunohistochemistry, biomarkers, cyclin D1, penile neoplasms
Transfected SARS-CoV-2 spike DNA for mammalian cell expression inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells and increases cancer cell viability after chemotherapy exposure Research Paper
Keywords: SARS-COV2 spike, p53, MDM2, chemotherapy, cancer
Correction: Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay Correction
Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay Research Paper
Keywords: circulating tumor DNA, whole genome sequencing, molecular residual disease, tumor-informed assay, analytical validation
G-quadruplex landscape and its regulation revealed by a new antibody capture method Research Paper
Keywords: DNA G-quadruplexes, G4-ChIP, CGGBP1, CTCF, G/C-skew
ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells Research Paper
Keywords: acute myeloid leukemia, pre-transplant regimens, venetoclax, thiotepa, busulfan